Brand Name DSUVIA National Stock Number (NSN) 6505-01-678-1097 Sufentnail NanoTabs

Award Notice Posted

Solicitation number
W81XWH20R0095
Agency
Awarded
to Acelrx Pharmaceuticals, Inc.
Set-aside
Total Small Business

Opportunity facts

Contract number
W81XWH20C0133 Federal contract award
Place of performance
Frederick MD 21702 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The Award Notice was published by the Department of the Army Medical Command on September 21, 2020. It notified of a contract award to AcelRx Pharmaceuticals, Inc. on September 20, 2020 for a firm fixed price contract valued at $3,559,365.50 over a four year base period and four option years. The contract is to procure 3,200 boxes of the FDA-approved brand name DSUVIA Sufentanil NanoTabs to support a comparative clinical trial being conducted by the U.S. Army Medical Materiel Development Activity between DSUVIA and Oral Transmucosal Fentanyl Citrate.

Notice text

Notification of contract award to AcelRx Pharmaceuticals, Inc., on 20 September 2020, in the amount of $3,559,365.50, inclusive of base and four (4) options.  

The requirement is for a firm fixed price contract to procure United States Food and Drug Administration (FDA) approved Brand name DSUVIA, National Stock Number (NSN) 6505-01-678-1097 Sufentnail NanoTabs over the course of a four (4) year period.

Basis for award was Lowest Price, Technically Acceptable (LPTA).

Awarded contract W81XWH20C0133 to ACELRX PHARMACEUTICALS, INC. for 3559365.50 on 2020-09-20.

Files

Notice history

Notice Type Posted
This notice Award Award Notice
Brand Name DSUVIA National Stock Number (NSN) 6505-01-678-1097 Sufentnail NanoTabs Latest solicitation Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors